SQX-logo
SQXlogo
  • My Dashboard
  • Bond Academy
  • Tools
    • Bond Screener
    • Issuer Directory
    • Portfolio Builder
    • Discussion Board
  • Data Partners
‌
‌
  • Home
  • My Dashboard
  • Bond Academy
  • Tools
  • Data Partners
  • LoginCreate a free account
SQX-logo
SQX-white-logo© SQX BONDS. All rights reserved | Privacy Policy | Terms and Conditions | Represent a financial institution? | Customer Support
Visit SQXBonds on linkedinVisit SQXBonds on LinkedInVisit SQXBonds on facebookVisit SQXBonds on LinkedInVisit SQXBonds on instagramVisit SQXBonds on LinkedInVisit SQXBonds on twitterVisit SQXBonds on LinkedInVisit SQXBonds on iplVisit SQXBonds on LinkedIn
  1. Screener
  2. Issuers index
  3. H
  4. H. Lundbeck AS

H. Lundbeck AS Bonds

H. Lundbeck AS, founded in 1915 and headquartered in Valby, Denmark, is a global pharmaceutical company dedicated to developing innovative treatments for brain disorders. The company specializes in therapies for psychiatric and neurological conditions, with key products including antidepressants and antipsychotic medications.

Bond NameCountryMaturityCoupon(%)
LUNDC 0.88% 2027-10-14 EURH. Lundbeck ASDenmark2027-10-140.8752.76
LUNDC 3.38% 2029-06-02 EURH. Lundbeck ASDenmark2029-06-023.3753.13
Showing results 1 - 2 of 2
Per page

Company overview and issue history are AI generated, and should not be cited or relied on without verification.

H. Lundbeck AS issue history

H. Lundbeck AS has a history of bond issuances dating back several years, with notable issuances including a €500 million bond in 2020 to refinance existing debt and support strategic growth initiatives. The company currently offers bonds with competitive yields compared to the pharmaceutical industry, reflecting strong investor confidence. Recently, they issued a green bond, aligning with sustainability goals while attracting environmentally conscious investors.